European Archives - Page 167 of 1586 - European Medical Journal

GI Challenges in Parkinson’s Disease

Parkinson’s disease (PD) affects at least 1% of people aged over 60 years and 2–3% of those aged over 65 years. PD is reported to be the…

World map with the Middle East highlight with a red glowing dot

Supply chains and trials hit by Middle East instability

Pharma companies are facing renewed pressure due to instability linked to the Middle East conflict.

Integrated Genomic Model Improves CAD Risk Prediction

The model identified approximately 13% of high-risk individuals who would not have been detected using polygenic risk scores alone.

AI-Assisted Melanoma Diagnosis Matches Dermatologists

Meta-analysis shows AI-assisted melanoma diagnosis performs similarly to dermatologists, though further validation is needed for routine clinical use.

Month in pharma news, explained

Month in pharma news, explained – March 2026

In this roundup, we take a look back at top moments from the pharmaceutical industry from March.

Psychedelic-Assisted Psychotherapy Reduces Mental Illness Symptoms

A single cycle of psychedelic-assisted psychotherapy has been shown to substantially reduce symptoms of depression and anxiety.

Antimicrobial Resistance Genes Elevated in Chronic Lung Disease

Study finds higher antimicrobial resistance genes in lung disease patients, with antibiotic use linked to increased resistance in airway microbiomes.

MASLD Linked to Rising Cirrhosis in Northern Mexico

In a northern Mexico cohort, MASLD now accounts for the largest share of chronic liver disease and cirrhosis cases.

Targeted MRI Safely Guides Myeloma Pain Care

Targeted MRI accurately assesses new bone pain in stable multiple myeloma, guiding management and reducing unnecessary whole-body scans.

ECR 2026 Interview: Patrizia Cornacchione

Patrizia Cornacchione. Assistant Professor, Università Cattolica del Sacro Cuore, Rome, Italy; President, European Federation of…